Skip to main content

Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.

Interested parties may participate in the call by dialing:

(877) 407-6176 (US Toll-Free)

+1 (201) 689-8451 (International)

Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=4jnXGdPH

Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Tripp Sullivan
SCR Partners, LLC
615-942-7077

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
337-504-3802

SOURCE: Viemed Healthcare, Inc.



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.16
-0.63 (-0.31%)
AAPL  260.43
-3.92 (-1.48%)
AMD  202.70
+2.58 (1.29%)
BAC  52.45
-0.91 (-1.71%)
GOOG  303.65
-0.29 (-0.10%)
META  642.82
-0.40 (-0.06%)
MSFT  397.17
-2.44 (-0.61%)
NVDA  186.84
-1.14 (-0.61%)
ORCL  156.44
+0.27 (0.17%)
TSLA  410.37
-0.95 (-0.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.